Bataille B, Page P
Service de Neurochirurgie, CHU, Poitiers.
Neurochirurgie. 1997;43(6):385-7.
Therapeutic results of 248 patients with primary central nervous system lymphoma reported in the SFNC series between 1980 and 1995 were analyzed. Clinical, biological and radiological prognostic factors were found to have a favorable impact on survival: a) age < 60 years; b) radiation therapy but without evidence of a dose-response relationship; c) radiation therapy in addition to chemotherapy; d) the use of systemic chemotherapy consisting of anthracyclines. In multivariate analysis, we identified 4 independent factors: a) radiotherapy (RR = 3), b) age (RR = 2.31), c) the use of chemotherapy consisting of anthracyclines (RR = 2.53), d) partial surgical resection but as an unfavourable prognostic factor (RR = 1.45).
对1980年至1995年间SFNC系列报道的248例原发性中枢神经系统淋巴瘤患者的治疗结果进行了分析。发现临床、生物学和放射学预后因素对生存率有有利影响:a)年龄<60岁;b)放射治疗,但无剂量反应关系的证据;c)化疗联合放射治疗;d)使用含蒽环类药物的全身化疗。多变量分析中,我们确定了4个独立因素:a)放射治疗(相对危险度=3),b)年龄(相对危险度=2.31),c)使用含蒽环类药物的化疗(相对危险度=2.53),d)部分手术切除,但作为不良预后因素(相对危险度=1.45)。